ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

21,593Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 335

$1.76M Total Retail Price of All Prescriptions

Rank: 1 out of 335

1,005 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

2% of this provider’s 1,005 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

0% of this provider’s 16,627 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

33% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$81 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
CARVEDILOL 1,118 733 1 1
CRESTOR 995 830 2 17
NIASPAN 902 776 10 3 35
METOPROLOL SUCCINATE 880 746 4 9
ATORVASTATIN CALCIUM 808 682 5 11
SIMVASTATIN 771 657 6 4
FUROSEMIDE 753 487 7 6
AMLODIPINE BESYLATE 702 587 8 5
ZETIA 695 544 9 34
HYDRALAZINE HCL 628 385 10 26
DIGOXIN 612 377 11 14
SPIRONOLACTONE 570 367 12 20
WARFARIN SODIUM 569 429 13 8
CLOPIDOGREL 508 427 14 7
LISINOPRIL 407 283 15 2
PLAVIX 402 328 16 12
POTASSIUM CHLORIDE 376 245 17 18
LOSARTAN POTASSIUM 372 312 18 16
AMIODARONE HCL 356 275 19 21
ISOSORBIDE MONONITRATE ER 351 265 20 10
RAMIPRIL 350 326 21 23
PRAVASTATIN SODIUM 337 270 22 13
PRADAXA 337 322 22 32
HYDROCHLOROTHIAZIDE 336 291 24 19
OMEPRAZOLE 269 219 25 29
RANEXA 269 207 25 25
DOXAZOSIN MESYLATE 237 205 27 57
CAPTOPRIL 228 141 28 103
BENAZEPRIL HCL 201 164 29 30
LIPITOR 198 125 30 40
METOPROLOL TARTRATE 190 152 31 3
ISOSORBIDE DINITRATE 189 103 32 63
LEVOTHYROXINE SODIUM 172 149 33 36
SOTALOL 156 132 34 24
EFFIENT 150 103 35 37
MULTAQ 143 125 36 41
WELCHOL 142 121 37 102
CILOSTAZOL 140 121 38 70
KLOR-CON M20 129 69 39 39
PANTOPRAZOLE SODIUM 127 110 40 48
TAMSULOSIN HCL 123 113 41 79
FAMOTIDINE 119 116 42 65
CLONIDINE HCL 103 82 43 33
CHLORTHALIDONE 100 94 44 66
FENOFIBRATE 99 65 45 47
ENALAPRIL MALEATE 92 81 46 38
NITROSTAT 88 71 47 22
ENOXAPARIN SODIUM 81 60 48 157
DIOVAN 79 74 49 28
LOVAZA 78 37 50 78
TIKOSYN 77 77 51 86
TRICOR 75 58 52 74
PACERONE 72 46 53 85
TRILIPIX 68 37 54 101
METFORMIN HCL 66 46 55 67
ALLOPURINOL 66 35 55 68
VYTORIN 64 52 57 80
DILTIAZEM ER 64 59 57 56
PROPAFENONE HCL 63 62 59 50
NEXIUM 63 24 59 72
GLIMEPIRIDE 58 37 61 97
QUINAPRIL HCL 57 46 62 76
ATENOLOL 55 49 63 15
COLCRYS 52 23 64 145
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.